このページの翻訳は実験的なもので、現在開発中です。お待ちしております

McMillan Shakespeare 将来の成長

Future 基準チェック /26

McMillan Shakespeare利益と収益がそれぞれ年間7.2%と4.1%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に73.4% 7%なると予測されています。

主要情報

7.2%

収益成長率

7.0%

EPS成長率

Professional Services 収益成長	15.5%
収益成長率	4.1%
将来の株主資本利益率	73.4%
アナリストカバレッジ	Good
最終更新日	29 Jul 2024

今後の成長に関する最新情報

Recent updates

McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings

Feb 23

We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease

Jun 15

McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year

Mar 06

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Oct 26

Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)

Aug 31

Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?

Jul 28

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Apr 01

Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend

Mar 06

McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment

Feb 09

Do Insiders Own Lots Of Shares In McMillan Shakespeare Limited (ASX:MMS)?

Jan 19

Are Insiders Buying McMillan Shakespeare Limited (ASX:MMS) Stock?

Jan 04

Is McMillan Shakespeare Limited (ASX:MMS) Trading At A 34% Discount?

Dec 20

At AU$11.83, Is McMillan Shakespeare Limited (ASX:MMS) Worth Looking At Closely?

Dec 06

Should We Be Cautious About McMillan Shakespeare Limited's (ASX:MMS) ROE Of 1.0%?

Nov 23

McMillan Shakespeare Limited (ASX:MMS) Insiders Increased Their Holdings

Sep 13

Is Now An Opportune Moment To Examine McMillan Shakespeare Limited (ASX:MMS)?

Aug 25

Investors Holding Back On McMillan Shakespeare Limited (ASX:MMS)

Aug 10

Does McMillan Shakespeare's (ASX:MMS) Statutory Profit Adequately Reflect Its Underlying Profit?

Aug 10

業績と収益の成長予測

ASX:MMS - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2027	571	106	122	127	2
6/30/2026	552	105	126	116	9
6/30/2025	538	97	116	111	9
6/30/2024	523	94	91	59	8
12/31/2023	481	76	-80	-60	N/A
9/30/2023	472	70	-36	-18	N/A
6/30/2023	464	64	8	25	N/A
12/31/2022	347	69	112	122	N/A
9/30/2022	383	68	111	121	N/A
6/30/2022	419	67	111	120	N/A
3/31/2022	601	68	114	124	N/A
12/31/2021	608	66	118	128	N/A
9/30/2021	576	63	151	162	N/A
6/30/2021	544	61	185	195	N/A
3/31/2021	508	27	221	231	N/A
12/31/2020	471	-7	257	266	N/A
9/30/2020	483	-3	215	227	N/A
6/30/2020	494	1	174	188	N/A
3/31/2020	520	32	149	166	N/A
12/31/2019	547	64	125	145	N/A
9/30/2019	548	64	119	139	N/A
6/30/2019	550	64	114	133	N/A
3/31/2019	549	57	112	130	N/A
12/31/2018	549	49	111	128	N/A
9/30/2018	547	50	107	123	N/A
6/30/2018	545	50	103	118	N/A
3/31/2018	544	56	73	86	N/A
12/31/2017	542	62	42	53	N/A
9/30/2017	533	65	N/A	50	N/A
6/30/2017	523	68	N/A	47	N/A
3/31/2017	518	76	N/A	52	N/A
12/31/2016	512	84	N/A	58	N/A
9/30/2016	508	83	N/A	76	N/A
6/30/2016	505	82	N/A	95	N/A
3/31/2016	478	79	N/A	53	N/A
12/31/2015	451	75	N/A	12	N/A
9/30/2015	420	71	N/A	-2	N/A
6/30/2015	390	67	N/A	-16	N/A
3/31/2015	379	67	N/A	20	N/A
12/31/2014	369	67	N/A	56	N/A
9/30/2014	358	61	N/A	47	N/A
6/30/2014	347	55	N/A	37	N/A
3/31/2014	339	53	N/A	37	N/A
12/31/2013	331	52	N/A	38	N/A
9/30/2013	331	57	N/A	33	N/A

アナリストによる今後の成長予測

収入対貯蓄率: MMSの予測収益成長率 (年間7.2% ) は貯蓄率 ( 2.4% ) を上回っています。

収益対市場: MMSの収益 ( 7.2% ) Australian市場 ( 12.9% ) よりも低い成長が予測されています。

高成長収益: MMSの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: MMSの収益 ( 4.1% ) Australian市場 ( 5.3% ) よりも低い成長が予測されています。

高い収益成長: MMSの収益 ( 4.1% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: MMSの自己資本利益率は、3年後には非常に高くなると予測されています ( 73.4 %)。

McMillan Shakespeare 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Consensus EPS estimates increase by 16%

Price target decreased by 7.3% to AU$18.81

Consensus revenue estimates fall by 15%

Price target increased by 8.6% to AU$18.96

Price target increased by 7.8% to AU$17.45

Price target increased to AU$13.63

Recent updates

Mcmillan Shakespeare Limited Announces Chief Financial Officer Appointments

Upcoming dividend of AU$0.76 per share

First half dividend of AU$0.76 announced

McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings

McMillan Shakespeare Limited to Report First Half, 2024 Results on Feb 20, 2024

Investor sentiment improves as stock rises 22%

Consensus EPS estimates increase by 16%

First half 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 20% undervalued

Price target decreased by 7.3% to AU$18.81

Now 23% undervalued after recent price drop

Now 20% undervalued after recent price drop

When Should You Buy McMillan Shakespeare Limited (ASX:MMS)?

Upcoming dividend of AU$0.66 per share at 7.0% yield

Consensus revenue estimates fall by 15%

Price target increased by 8.6% to AU$18.96

McMillan Shakespeare (ASX:MMS) Has A Pretty Healthy Balance Sheet

Mcmillan Shakespeare Limited Announces Dividend for the Six Month Ended June 30, 2023, Payable on September22, 2023

New major risk - Financial position

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

An unknown buyer acquired Asset Finance Aggregation business of McMillan Shakespeare Limited.

Price target increased by 7.8% to AU$17.45

A Look At The Fair Value Of McMillan Shakespeare Limited (ASX:MMS)

We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease

McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year

Upcoming dividend of AU$0.58 per share at 10.0% yield

First half 2023 earnings released: EPS: AU$0.48 (vs AU$0.39 in 1H 2022)

McMillan Shakespeare Limited, Annual General Meeting, Oct 27, 2023

Independent Non-Executive Chairman recently bought AU$62k worth of stock

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$0.74 per share

McMillan Shakespeare Limited Appoints Arlene Tansey as Independent Non-Executive Director, Effective 7 November 2022

McMillan Shakespeare Limited Announces Retirement of Tim Poole From the Board of Directors, Effective 31 August 2022

Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to AU$13.63

McMillan Shakespeare Limited Declares Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on November 10, 2022

Investor sentiment improved over the past week

Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?

Price target decreased to AU$13.01

Price target increased to AU$14.29

Price target decreased to AU$13.23

Upcoming dividend of AU$0.34 per share

McMillan Shakespeare Limited, Annual General Meeting, Oct 28, 2022

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

McMillan Shakespeare Limited Declares an Interim Fully Franked Dividend, Payable on 25 March 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of AU$0.31 per share

McMillan Shakespeare Limited (ASX:MMS) acquired Plan Tracker.

Full year 2021 earnings released: EPS AU$0.79 (vs AU$0.016 in FY 2020)

Price target increased to AU$14.84

Independent Non-Executive Director has left the company

Independent Non-Executive Director has left the company

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Non-Executive Director recently sold AU$1.5m worth of stock

New 90-day low: AU$11.30

Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend

First half 2021 earnings released: EPS AU$0.33 (vs AU$0.42 in 1H 2020)

McMillan Shakespeare Limited (ASX:MMS) acquired remaining 50% stake in Maxxia Limited for AUD 1.8 million.

McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment

McMillan Shakespeare Limited to Report Fiscal Year 2021 Results on Aug 24, 2021

Price target raised to AU$12.00

New 90-day high: AU$12.68

Do Insiders Own Lots Of Shares In McMillan Shakespeare Limited (ASX:MMS)?

Are Insiders Buying McMillan Shakespeare Limited (ASX:MMS) Stock?

New 90-day high: AU$12.26